EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)

Senlin Hou, Ming Xiong, Binxian Xu, Duze Zhao, Zhinan Du, Dongjun Fu, Wei Lu, Junqing Hou, Weiguo Chen

Research journal · 2025 · 1 (1)

DOI: 10.65281/736336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research journal, 2025. Verfasst von Senlin Hou und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hou, S., Xiong, M., Xu, B., Zhao, D., Du, Z., Fu, D., Lu, W., Hou, J., & Chen, W. (2025). Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal, 1(1). https://doi.org/10.65281/736336

Vancouver

Hou S, Xiong M, Xu B, Zhao D, Du Z, Fu D, et al. Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal. 2025;1(1). doi:10.65281/736336

BibTeX
@article{Hou2025,
  author = {Hou, Senlin and Xiong, Ming and Xu, Binxian and Zhao, Duze and Du, Zhinan and Fu, Dongjun and Lu, Wei and Hou, Junqing and Chen, Weiguo},
  title = {Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)},
  journal = {Research journal},
  year = {2025},
  volume = {1},
  number = {1},
  doi = {10.65281/736336}
}
Kostenlos starten →